Skip to content

Pharma K Consulting

Active Private limited companyfounded 2024active for 2 yearsSijsjeslaan 25B, 1950 KraainemKBO/BCE: BE 1014.282.676

Lifetime

1 annual account with figures
peak of €49,556 in 2025
€49,556 
peak of €38,820 in 2025
€38,820 
peak of €38,820 in 2025
€38,820 
€13,138 
Board1 name since 2024
1 director
Documentsfilings and deeds
21-06-202640 days before the deadline
2025micro format
First year with figures

Key points

from the 2025 annual accounts

Turnover

≈ €200,000 estimated

The micro format states no turnover.

Position in the sector

€38,820

Higher net result than 80% of companies in other professional activities. Sector median €9,115 · 4,571 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as Pharma K Consulting has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for Pharma K Consulting. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 26-09-2024
  • founderdeed of 01-10-2024
  • 100 sharesdeed of 01-10-2024
Board & ownership

Recent changes

Amendment of the articles General meeting of 22-09-2026 · Gazette deed
Registered office moved from Nivelles to Kraainem The registered office moved from vieux chemin de Braine-le-Comte 61, 1400 Nivelles to avenue des Tarins 25В, 1950 Kraainem · Registered office clause: avenue des Tarins 25B, 1950 Kraainem · General meeting of 22-09-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:1014282676
Incorporation Founding capital of €2,000, 100 shares · Founded by · appointed as director · published on 01-10-2024 · Gazette deed
All 6 events

Comparable companies

same main activity, similar in size and age
Company
Pharma K Consulting Kraainem - - 74.7% -
International Offshore Safety and Health Advice Rev 2.0 Schilde - - 66.6% -
SafetyWise Solutions Turnhout - - 69.9% -
Ha-Consultancy Beerse €163,872 28.8% 63.5% -
Axtorm Molenbeek-Saint-Jean €87,333 48.4% 65.8% -
CISELIA Watermael-Boitsfort - - 73.6% -
Lapcon Edegem - - 80.1% -

These companies have the same main activity as Pharma K Consulting: other professional, scientific and technical activities (NACE 74999). They are comparable in size and age: total assets between €44,100 and €57,200, founded between 2024 and 2025.

Official details

Source: KBO
Status
Active since 27-09-2024Normal situation
Activity
Other professional, scientific and technical activitiesNACE 74999and 2 others
Establishment unit
2.365.243.4461950 Kraainem, since 27-09-2024
Financial year end
31 December
Peppol
Reachable since 09-09-2025
Company details

Annual accounts 2025

€51,958
Filing
Filed on 21-06-2026, 40 days before the end of the filing period
Financials

Insights on Pharma K Consulting

Pharma K Consulting has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €38,820 and a net result of €38,820.

Its solvency ranks better than 75% of 4,577 sector peers (NACE 74) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Pharma K Consulting

What is the company number of Pharma K Consulting?
The company number of Pharma K Consulting is 1014.282.676. The VAT number is the same number with BE in front: BE 1014.282.676.
Where is Pharma K Consulting based?
The registered office is at Sijsjeslaan 25B, 1950 Kraainem.Company details
What does Pharma K Consulting do?
According to the KBO register, the main activity is other professional, scientific and technical activities (NACE 74999).
What is the legal form of Pharma K Consulting?
Pharma K Consulting is a private limited company (BV).
When was Pharma K Consulting founded?
Pharma K Consulting was founded on 27-09-2024.
Is Pharma K Consulting still active?
Yes, Pharma K Consulting is an active enterprise in the KBO register.
What is the turnover of Pharma K Consulting?
The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €49,556 and 3,264 comparable companies of the same size. It probably lies between €120,000 and €350,000. It is a rough estimate.Financials
Is Pharma K Consulting profitable?
In financial year 2025, Pharma K Consulting made a profit of €38,820.
Where can I find the annual accounts of Pharma K Consulting?
Pharma K Consulting filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.